• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2420-0007
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problems Bradycardia (1751); Low Blood Pressure/ Hypotension (1914)
Event Date 02/28/2019
Event Type  Injury  
Manufacturer Narrative
The customer¿s report of an over infusion incident involving the drug precedex was not confirmed or replicated during the investigation; however the incident disposable set was found to have an eccentric (out of round) condition.Visual inspection of the disposable iv set identified an eccentric condition.Physical inspection noted the pump module to be in good condition with no damage or anomalies observed.Review of the log shows no programming errors or any existing malfunctions that would indicate an over infusion had occurred.The returned infusion system had under infused with an error at -6% rate accuracy testing found the device to be within specification with no unregulated flow.The cause of the overinfusion was the eccentric (out of round) condition of the silicone segment, which has been identified to be a contributing factor to incidents of over infusion.
 
Event Description
It was reported that precedex (0.2 mcg/kg/hr) was initiated at 1015 at a rate of 3.5ml/hr, and 2 hours later reduced to 1.9ml/hr (0.1 mcg/kg/hr) due to the patient experiencing hypotension and bradycardia.By 1610, there was 5ml remaining in the bag, however the pump indicated a vtbi of 70ml.The initial vtbi was 85ml (15ml to prime the line).Two nurses double checked the infusion settings and pump, however no errors were found.The infusion was stopped; the line, medication and pump module were removed and the doctor was notified of the event.There was no patient harm reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
ade ajibade
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key8811935
MDR Text Key151737229
Report Number9616066-2019-01796
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public7613203021012
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2420-0007
Device Catalogue Number2420-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/10/2019
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8015,8100, THERAPY DATE (B)(6) 2019
Patient Outcome(s) Required Intervention;
Patient Weight75
-
-